Evaluation of the "Grasp Site" After Peeling of Epiretinal Membranes
NCT ID: NCT06753539
Last Updated: 2025-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2023-05-12
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. are there differences in grasp attempts between both forceps
2. are there differences in Instrument tissue interactions between both forceps
3. are there differences in postsurgical anatomical and functional outcomes at the grasp site between both forceps.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study of Sharkskin Versus Grieshaber Forceps During ILM Peeling
NCT04459949
Comparison of Efficacy Between ILM Forceps
NCT06536569
Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes
NCT06459284
Choroidal Thickness Vitrectomy
NCT02617147
Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling
NCT03457584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Diaz et al. demonstrated that there are postoperative changes in the "nerve fiber layer" after ILM peeling, but in that study, no recording of instrument/tissue interactions was performed using iOCT.
The aim of this study is to compare the novel ILM sharkskin forceps with a conventional ILM forceps utilizing iOCT assistance during surgery at this "grasp site".
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ILM sharkskin forceps
Patients were operated on using an ILM forceps with a laser-modified microstructure on the branches.
ILM forceps - membrane grasping
grasping the epiretinal membrane at the starting location, using pinch peeling, is performed with an ILM forceps.
conventional ILM forceps
Patients were operated on using a conventional ILM forceps with plain surfaces on the branches.
ILM forceps - membrane grasping
grasping the epiretinal membrane at the starting location, using pinch peeling, is performed with an ILM forceps.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ILM forceps - membrane grasping
grasping the epiretinal membrane at the starting location, using pinch peeling, is performed with an ILM forceps.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sheduled surgery (vitrectomy with membrane peeling), as defined by vision loss and/or metamorphopsia
* Age 18 and older
* Written informed consent for participation in the study
Exclusion Criteria
* Pregnancy (pregnancy test will be performed in women of reproductive age)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prim. Prof. Dr. Oliver Findl, MBA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Prim. Prof. Dr. Oliver Findl, MBA, Sponsor of the study
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Leisser, MD
Role: PRINCIPAL_INVESTIGATOR
Mein Hanusch-Krankenhaus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanusch Hospital, Department of Ophthalmology
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology. 1997 Jun;104(6):1033-40. doi: 10.1016/s0161-6420(97)30190-0.
Machemer R. [The surgical removal of epiretinal macular membranes (macular puckers) (author's transl)]. Klin Monbl Augenheilkd. 1978 Jul;173(1):36-42. German.
Leisser C, Palkovits S, Hienert J, Ullrich M, Zwickl H, Georgiev S, Findl O. Effect of Iatrogenic Traction during Macular Peeling Surgery on Postoperative Microperimetry. Ophthalmic Res. 2021;64(2):273-279. doi: 10.1159/000507633. Epub 2020 Apr 1.
Leisser C, Hackl C, Hirnschall N, Findl O. Effect of Subfoveal and Extrafoveal Hyporeflective Zones due to Iatrogenic Traction during Membrane Peeling for Epiretinal Membranes on Postoperative Outcomes. Ophthalmologica. 2020;243(4):297-302. doi: 10.1159/000505214. Epub 2019 Dec 5.
Diaz RI, Randolph JC, Sigler EJ, Calzada JI. Intraoperative grasp site correlation with morphologic changes in retinal nerve fiber layer after internal limiting membrane peeling. Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb;45(1):45-9. doi: 10.3928/23258160-20131220-06.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.